The aim of this work is the synthesis of new grafted PVA polymer with a derivative of Erythro-ascorbic acid (pentulosono-ɣ -lactone-2, 3-enedianisoate). All synthesized compounds were characterized by thin layer chromatography (TLC) and FTIR spectra and aldehyde was also characterized by (U.V-Vis), 1HNMR, 13CNMR and mass spectra. They were also evaluated for antimicrobial properties by dilute method against four pathogenic bacteria (Escherichia coli ,Klebsiella pneumonae, Staphylococcus aureus, Staphylococcus Albus) and two fungal (Aspergillus Niger, Yeast). All polymer metal complexes showed good activities against the various microbial isolates. The polymer metal complexes showed higher activity than the free polymer. The order of increasing activities was polymer < pol-Mn < pol-Ni < pol-Co < pol-Cu < pol-Hg < pol-Ag. The results provided evidence that the studied complexes might indeed be potential sources of antimicrobial agents and these would further enable us to evaluate their utility in biomedical field.
Synthesis, Characterization, and Anti-Microbial Study of Metal Complexes of Polycyclicacetal derived from PVA & Erythro-Ascorbic acid derivative
Polycyclicacetal
polymer metal complexes
antibacterial
antifungal
activity
Publication Date
Sat May 30 2026
Journal Name
Iraqi Journal Of Science
Leucine-rich alpha-2-glycoprotein-1 as a Potential biomarker for polycystic ovary syndrome
diabetes millets
Leucine-rich alpha-2-glycoprotein-1
Luteinizing hormone
Percentage Body Fat
Polycystic ovary syndrome
Xanthine oxidase activity
Polycystic ovary syndrome (PCOS) is a common endocrine disorder affecting women of reproductive age, characterized by anovulatory, infertility and metabolic disturbances. This study aimed to assess the diagnostic accuracy of Leucine-rich alpha-2-glycoprotein-1 (LRG1) and xanthine oxidase (XO) activity as novel biomarkers for PCOS, as well as to explore the relationship between LRG1 and XO activity across different groups. A total of 150 married women, aged 18-46 years were enrolled and divided into three groups: 50 with PCOS under treatment, 50 PCOS without treatment conditions shared by women with polycystic ovary conditions, and 50 healthy women. Serum samples were analysed to measure LRG1, xanthine oxidase (XO) activity,
... Show More
